Connection

Jeffrey Hammerbacher to Female

This is a "connection" page, showing publications Jeffrey Hammerbacher has written about Female.
Connection Strength

0.093
  1. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer. 2018 01 22; 18(1):87.
    View in: PubMed
    Score: 0.032
  2. Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. Cancer Immunol Res. 2017 01; 5(1):84-91.
    View in: PubMed
    Score: 0.030
  3. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
    View in: PubMed
    Score: 0.009
  4. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018 05 14; 33(5):843-852.e4.
    View in: PubMed
    Score: 0.008
  5. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. PLoS Med. 2017 05; 14(5):e1002309.
    View in: PubMed
    Score: 0.008
  6. Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations. Sci Rep. 2016 Feb 09; 6:21161.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.